# Intravenous Ciprofloxacin Versus Intravenous Ceftriaxone: Spontaneous Bacterial Peritonitis in Cirrhosis of Liver

> **NCT07552870** · NA · COMPLETED · sponsor: **Shahida Islam Medical Complex** · enrollment: 310 (actual)

## Conditions studied

- Cirrhosis

## Interventions

- **DRUG:** intravenous ciprofloxacin
- **DRUG:** intravenous ceftriaxone

## Key facts

- **NCT ID:** NCT07552870
- **Lead sponsor:** Shahida Islam Medical Complex
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-01-15
- **Primary completion:** 2026-04-14
- **Final completion:** 2026-04-14
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07552870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07552870, "Intravenous Ciprofloxacin Versus Intravenous Ceftriaxone: Spontaneous Bacterial Peritonitis in Cirrhosis of Liver". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07552870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*